Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sage Therapeutics Inc. buy Piper Sandler

Start price
€5.63
02.01.25 / 50%
Target price
€8.77
02.01.26
Performance (%)
35.22%
Price
€7.60
31.07.25
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler for Sage Therapeutics Inc. has seen massive gains of 35.22%. This prediction currently runs until 02.01.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Sage Therapeutics Inc. - -
iShares Core DAX® 0.396% -0.010%
iShares Nasdaq 100 0.881% -0.819%
iShares Nikkei 225® 1.405% -3.232%
iShares S&P 500 0.259% -0.051%

Comments by Piper_Sandler for this prediction

In the thread Sage Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 35.22%
Target price 8.768
Change
Ends at 02.01.26

Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Piper Sandler from $26.00 to $9.00. They now have an "overweight" rating on the stock.
Ratings data for SAGE provided by MarketBeat

Stopped prediction by Piper_Sandler for Sage Therapeutics Inc.

buy
Sage Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.99
30.10.24
€23.94
30.10.25
26.96%
31.10.25